Cosmetic Surgery with Autoimmune Disease in Korea: Lupus, Hashimoto, and What's Possible

Patients with autoimmune disease are often told they can\'t have cosmetic surgery — but that\'s rarely categorically true. Disease-stable patients with controlled autoimmune conditions can have most cosmetic procedures with appropriate coordination. Korean clinics serving foreign patients increasingly include autoimmune-history evaluation in pre-op assessment. This guide explains what\'s realistic for various conditions.

The general principle

  • Autoimmune disease isn\'t an absolute contraindication to cosmetic surgery.
  • Disease activity and control matter more than diagnosis.
  • Perioperative coordination with treating specialist essential.
  • Procedure-specific considerations vary by condition.
  • Some conditions require deferral during active flares.

Hashimoto\'s thyroiditis

Generally safe with control

  • If thyroid function controlled with medication, generally not significant contraindication.
  • Confirm TSH within target range before surgery.
  • Continue thyroid replacement throughout perioperative period.
  • Bring medication list to clinic.
  • Anesthesia generally proceeds normally.

Considerations

  • Medication should be optimized 6+ weeks before major surgery.
  • Healing slightly slower if poorly controlled.
  • Possible interaction with thyroid eye disease (Graves\' overlap).
  • Cosmetic procedures generally well-tolerated.

Systemic lupus erythematosus (SLE)

Active disease — defer

  • Active flares (joint pain, kidney involvement, skin rash) require deferral.
  • Stable inactive disease for 6+ months preferable before elective procedures.
  • Photosensitivity affects laser treatment decisions.
  • Steroid use affects healing and infection risk.

Procedure-specific lupus considerations

  • Lasers — Often avoided due to UV photodamage potential triggering flare.
  • Injectables — Hyaluronic acid generally well-tolerated.
  • Botox — Safety not well-established; case-by-case.
  • Surgery — Increased bleeding, slower healing, infection risk if on immunosuppression.
  • Filler grafts — Some physicians avoid concerns about disease reactivation.

Coordination required

  • Rheumatologist clearance before procedures.
  • Recent labs (anti-dsDNA, complement levels, kidney function).
  • Discussion of immunosuppression dose around surgery.
  • Antibiotic prophylaxis consideration.
  • Conservative approach over aggressive procedures.

Rheumatoid arthritis (RA)

Generally manageable

  • Disease control critical (low DAS-28 score).
  • Medication management essential.
  • Methotrexate continuation generally fine for cosmetic procedures.
  • Biologics (TNF inhibitors) — stop 1–2 weeks pre-surgery typically.
  • Steroid stress dosing for major procedures.

Joint considerations

  • Positioning during surgery may need adjustment.
  • Cervical spine instability evaluation if relevant.
  • Hand and finger joint involvement may affect dexterity assessment.

Scleroderma / systemic sclerosis

Specific challenges

  • Skin tightness affects surgical access.
  • Microvascular changes affect healing.
  • Esophageal dysmotility affects positioning.
  • Pulmonary involvement affects anesthesia.
  • HA fillers actually have shown clinical benefit in scleroderma patients.

What\'s safe

  • HA fillers for facial volume — well-tolerated.
  • Conservative procedures with experienced surgeon.
  • Multi-disciplinary coordination.

What\'s risky

  • Major surgical procedures — high complication risk.
  • Aggressive resurfacing.
  • Pulmonary compromise during long anesthesia.

Psoriasis / psoriatic arthritis

Considerations

  • Active skin disease affects surgical site selection.
  • Köbner phenomenon — surgical trauma may trigger plaques at incisions.
  • Biologic medications affect immune function.
  • Generally compatible with most cosmetic procedures.

Treatment approach

  • Treat active disease before elective surgery.
  • Skin clear at surgical sites preferred.
  • Coordinate biologic timing.
  • Watch for new lesions at incision sites.

Multiple sclerosis (MS)

Considerations

  • Stable disease generally permits cosmetic procedures.
  • Avoid stress (potential flare trigger).
  • Anesthesia considerations for those with respiratory involvement.
  • Most cosmetic procedures well-tolerated.

Inflammatory bowel disease (Crohn\'s, ulcerative colitis)

Considerations

  • Disease control essential.
  • Steroid use affects healing.
  • Nutritional status affects recovery.
  • Generally permits cosmetic procedures with control.

Pre-operative coordination

Documentation needed

  • Recent specialist letter confirming disease stability.
  • Current medication list with doses.
  • Recent labs (within 3 months for stable disease).
  • Disease-specific markers (anti-dsDNA, RF, etc.).
  • Imaging if relevant.

Communication with Korean clinic

  • Disclose autoimmune history at virtual consultation.
  • Send specialist letter before in-person visit.
  • Discuss medication holds and adjustments.
  • Confirm anesthesia adjustments needed.
  • Clarify deferral criteria if disease unstable at arrival.

Medication management around surgery

Steroids

  • Continue at maintenance dose typically.
  • Stress dosing for major procedures.
  • Don\'t suddenly discontinue.
  • Wound-healing impact considered.

Methotrexate

  • Generally continued for cosmetic procedures.
  • Low-dose weekly schedule fine.
  • Increased infection risk monitored.

Biologics (TNF inhibitors, IL-6 inhibitors, JAK inhibitors)

  • Typically stop 1–2 weeks pre-surgery.
  • Resume after wound healing (typically 2 weeks post-op).
  • Rheumatologist coordination essential.
  • Disease may flare during hold period.

Hydroxychloroquine

  • Generally continued.
  • Safe through perioperative period.
  • Lupus disease control benefit.

Specific procedure suitability

Generally safe

  • HA fillers (most autoimmune conditions).
  • Botox in stable disease.
  • Conservative skin treatments (peels, mild lasers — except photosensitive conditions).
  • Non-invasive procedures.

Caution required

  • Surgical procedures during active flares.
  • Lasers in photosensitive lupus.
  • Aggressive resurfacing in scleroderma.
  • Anesthesia in pulmonary-involved disease.

Generally deferred

  • Elective surgery during active flare.
  • Major procedures with significant immunosuppression.
  • Treatments triggering specific disease (UV in lupus).

Korean clinic experience with autoimmune patients

  • Major academic-affiliated clinics often more experienced.
  • Specific clinics specialize in complex patient populations.
  • Pre-op questionnaires increasingly include autoimmune screening.
  • Some clinics decline complex patients; others accommodate.
  • Honest discussion at consultation essential.

What patients should expect

  • More extensive pre-op evaluation.
  • Potentially longer recovery.
  • Closer monitoring during healing.
  • Possible need to adjust normal medication schedule.
  • Coordination back home for ongoing care.

Red flags from clinics

  • Refusal to engage with autoimmune history details.
  • Unwillingness to coordinate with home rheumatologist.
  • Pressure to proceed despite disease activity.
  • Lack of awareness of medication interactions.
  • Generic "you\'ll be fine" reassurance without evaluation.

Patient self-advocacy

  • Bring medication and disease-control documentation.
  • Ensure clinic understands your specific condition.
  • Ask about complication rates in autoimmune patients.
  • Consider declining procedures recommended without proper evaluation.
  • Maintain ongoing care with home specialist.

The honest framing

Autoimmune disease and cosmetic surgery aren\'t mutually exclusive — but they require careful coordination, disease-control, and surgeon experience with complex patients. The patients who navigate this well disclose fully, coordinate with home specialists, defer when disease is active, and select Korean clinics with experience managing complex patient populations. The patients who minimize disease history or pursue surgery during active disease face higher complication rates and worse outcomes. Match procedure timing to disease control, coordinate care across providers, and accept that some procedures may not be appropriate for some conditions even with optimal management.

← 목록으로